School of Medicine
Showing 1-10 of 26 Results
Tayyeba K. Ali, MD
Affiliate, School of Medicine - Biomedical Ethics
BioTayyeba K. Ali, MD, a Board Certified ophthalmologist, specializes in complex corneal disease and uveitis. She sees patients at Palo Alto Medical Foundation / Sutter Health in Sunnyvale, CA. Dr. Ali also works as a medical specialist on contract for Google.
Prior to completing two fellowships in cornea, external disease, refractive surgery and uveitis at Bascom Palmer Eye Institute, ranked #1 eye hospital in the United States by U.S. News & World Report, Dr. Ali finished her ophthalmology residency at the Jones Eye Institute / UAMS. She earned her medical degree from Emory University School of Medicine and completed her undergraduate training in English literature and creative writing from Agnes Scott College.
Dr. Ali has received many academic and teaching awards including the Bascom Palmer Fellow of the Year Award and the Jone’s Eye Dean’s Faculty Award. She has delivered dozens of lectures on the national and international level and published numerous meeting abstracts and peer-reviewed journal articles.
As a second generation American, Tayyeba finds herself dwelling on migrant and refugee stories, their need for ethnic and religious identity, and the repercussions of these journeys. She is keenly interested in international medicine, resident education, health technology and taking a closer look at the moral crossroads we face in healthcare. She is the Associated Director for Pegasus Physician Writers at Stanford as well as the Senior Fiction Editor for the medical literary magazine, The Pegasus Review; she has a particular affinity for colons (grammatically, not anatomically, speaking) and semicolons.
MD Student, expected graduation Spring 2026
Portraiture Assistant, School of Medicine - Biomedical Ethics
BioMelanie Ambler is an aspiring physician-artist-scientist, interested in the integration of the arts into the medical field. She is a classically-trained cellist and founded two live virtual concert series for patients and care providers in both the United States and France. In 2019, she received a Fulbright Fellowship for study and research in the city of Caen, France. She pursued a master's in Neuroscience at the Université de Caen-Normandie, and performed a research study with the Neuroimaging Lab of Human Memory regarding the ability of patients with clinical amnesia to recognize new melodies or paintings. She is currently a musician on call for the nonprofit Project: Music Heals Us and plays weekly one-on-one virtual concerts for critically ill patients.
Melanie hopes to continuing bridging the arts and medicine during her time at Stanford Medicine by researching promising interventions and then putting them into practice as a care provider.
Academic Prog Prof 3, School of Medicine - Biomedical Ethics
Current Role at StanfordExecutive Director of the Medicine & the Muse Program
LEAD Program for Residents, Mentor
Member of Stanford School of Medicine JEDI Collective
Member SCBE Diversity Committee
Steering Committee Member: Health Humanities Consortium
Teaching Lead, War Literature & Writing class for military affiliated students
Co-teacher, War and Fiction for non military and military affiliated students
Facilitator, Literature & Medicine Dinner & Discussion Series
Co-lead Stuck@Home Concert series
Co-Lead: Frankenstein@200 2017-2018 Initiative
Stanford Supervisory Academy (completed)
Sr Research Scholar, School of Medicine - Biomedical Ethics
BioMeghan Halley, PhD, MPH, is a Senior Research Scholar in the Center for Biomedical Ethics (SCBE) at Stanford University. She completed her doctorate in medical anthropology from Case Western Reserve University in 2012, and additional training in health services research at the Palo Alto Medical Foundation Research Institute from 2012 through 2016. Her current research focuses at the intersection of the ethics and economics of new genomic technologies. Her current projects include examining ethical issues related to sustainability and governance of patient data and relationships when large clinical genomic studies transition to new models of funding; ethnographic work exploring how diverse stakeholders perceive value in the use of genome sequencing for diagnosis of rare diseases; and the development of new measures for assessing patient-centered outcomes in pediatric rare diseases.